Vitamin D and oxidative stress

Vitamin D: Oxidative Stress, Immunity, and Aging

Volumn , Issue , 2012, Pages 131-150

  Ting, Huei Ju ^a   Lee, Yi Fen ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84884814347     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1201/b13714     Document Type: Chapter

References (104)

1. Feldman, D., J. W. Pike, and J. S. Adams. 2011. Vitamin D. 3rd edition, Amsterdam, Boston: Academic Press.
2. Garcion, E. et al. 2002. New clues about vitamin D functions in the nervous system. Trends Endocrinol Metab 13(3):100-105.
3. 3: A helpful immunomodulator. Immunology 134(2):123-139.
4. Takiishi, T. et al. 2010. Vitamin D and diabetes. Endocrinol Metab Clin North Am 39(2):419-446.
5. Plum, L. A. and H. F. De Luca. 2010. Vitamin D, disease and therapeutic opportunities. Nat Rev Drug Discov 9(12):941-955.
6. Trump, D. L., K. K. Deeb, and C. S. Johnson. 2010. Vitamin D: Considerations in the continued development as an agent for cancer prevention and therapy. Cancer J 16(1):1-9.
7. 3, a steroid hormone that produces biologic effects via both genomic and nongenomic pathways. J Steroid Biochem Mol Biol 41(3-8):231-240.
8. Casarett, L. J., J. Doull, and C. D. Klaassen. 2008. Casarett and Doull’s Toxicology: The Basic Science of Poisons. 7th edition, New York: McGraw-Hill. xv, 1310 pp., 1 leaf of plates.
9. Newmeyer, D. D. and S. Ferguson-Miller. 2003. Mitochondria: Releasing power for life and unleashing the machineries of death. Cell 112(4):481-490.
10. Balaban, R. S., S. Nemoto, and T. Finkel. 2005. Mitochondria, oxidants, and aging. Cell 120(4):483-495.
11. Calabrese, E. J. 2001. Nitric oxide: Biphasic dose responses. Crit Rev Toxicol 31(4-5):489-501.
12. Goswami, S. K., N. Maulik, and D. K. Das. 2007. Ischemia-reperfusion and cardioprotection: A delicate balance between reactive oxygen species generation and redox homeostasis. Ann Med 39(4):275-289.
13. Mena, S., A. Ortega, and J. M. Estrela. 2009. Oxidative stress in environmental-induced carcinogenesis. Mutat Res 674(1-2):36-44.
14. Savolainen, K. M. et al. 1998. Interactions of excitatory neurotransmitters and xenobiotics in excitotoxicity and oxidative stress: Glutamate and lead. Toxicol Lett 102-103:363-367.
15. Montgomery, E. B. Jr. 1995. Heavy metals and the etiology of Parkinson’s disease and other movement disorders. Toxicology 97(1-3):3-9.
16. Rock, E. and A. DeMichele. 2003. Nutritional approaches to late toxicities of adjuvant chemotherapy in breast cancer survivors. J Nutr 133(11 Suppl 1):3785S-3793S.
17. Mason, R. P. and C. F. Chignell. 1981. Free radicals in pharmacology and toxicology-Selected topics. Pharmacol Rev 33(4):189-211.
18. Riley, P. A. 1994. Free radicals in biology: Oxidative stress and the effects of ionizing radiation. Int J Radiat Biol 65(1):27-33.
19. Bickers, D. R. and M. Athar. 2006. Oxidative stress in the pathogenesis of skin disease. J Invest Dermatol 126(12):2565-2575.
20. Drummond, G. R. et al. 2011. Combating oxidative stress in vascular disease: NADPH oxidases as therapeutic targets. Nat Rev Drug Discov 10(6):453-471.
21. Stoll, G., S. Jander, and M. Schroeter. 2002. Detrimental and beneficial effects of injury-induced inflammation and cytokine expression in the nervous system. Adv Exp Med Biol 513:87-113.
22. 3 upregulated protein 1 (VDUP1) is a regulator for redox signaling and stress-mediated diseases. J Dermatol 33(10):662-669.
23. Kinnula, V. L. and J. D. Crapo. 2003. Superoxide dismutases in the lung and human lung diseases. Am J Respir Crit Care Med 167(12):1600-1619.
24. Weiss, S. L. and R. A. Sunde. 1997. Selenium regulation of classical glutathione peroxidase expression requires the 3′ untranslated region in Chinese hamster ovary cells. J Nutr 127(7):1304-1310.
25. Nenoi, M. et al. 2001. Regulation of the catalase gene promoter by Sp1, CCAAT-recognizing factors, and a WT1/Egr-related factor in hydrogen peroxide-resistant HP100 cells. Cancer Res 61(15):5885-5894.
26. Fong, W. H. et al. 2010. Antiapoptotic actions of PPAR-gamma against ischemic stroke. Mol Neurobiol 41(2-3):180-186.
27. Dalton, T. P. et al. 2004. Genetically altered mice to evaluate glutathione homeostasis in health and disease. Free Radic Biol Med 37(10):1511-1526.
28. Rhee, S. G. et al. 2005. Controlled elimination of intracellular H(2)O(2): Regulation of peroxiredoxin, catalase, and glutathione peroxidase via post-translational modification. Antioxid Redox Signal 7(5-6):619-626.
29. Hussain, S. P. et al. 2004. p53-induced upregulation of MnSOD and GPx but not catalase increases oxidative stress and apoptosis. Cancer Res 64(7):2350-2356.
30. Pi, J., M. L. Freeman, and M. Yamamoto. 2010. Nrf2 in toxicology and pharmacology: The good, the bad and the ugly? Toxicol Appl Pharmacol 244(1):1-3.
31. Siegel, D. et al. 2004. NAD(P)H:quinone oxidoreductase 1: Role as a superoxide scavenger. Mol Pharmacol 65(5):1238-1247.
32. Turkseven, S. et al. 2005. Antioxidant mechanism of heme oxygenase-1 involves an increase in superoxide dismutase and catalase in experimental diabetes. Am J Physiol Heart Circ Physiol 289(2): H701-H707.
33. Arner, E. S. 2009. Focus on mammalian thioredoxin reductases-important selenoproteins with versatile functions. Biochim Biophys Acta 1790(6):495-526.
34. Immenschuh, S. and E. Baumgart-Vogt. 2005. Peroxiredoxins, oxidative stress, and cell proliferation. Antioxid Redox Signal 7(5-6):768-777.
35. 3) against the neurotoxicity of glutamate and reactive oxygen species in mesencephalic culture. Neuropharmacology 40(6):761-771.
36. 3 and some putative steroid neuroprotective agents on the hydrogen peroxide-induced damage in neuroblastoma-glioma hybrid NG108-15 cells. Acta Pol Pharm 60(5):351-355.
37. Husain, K. et al. 2009. Combination therapy with paricalcitol and enalapril ameliorates cardiac oxidative injury in uremic rats. Am J Nephrol 29(5):465-472.
38. Mizobuchi, M. et al. 2010. Myocardial effects of VDR activators in renal failure. J Steroid Biochem Mol Biol 121(1-2):188-192.
39. 3 on cytokine-treated human pancreatic islets. J Endocrinol 169(1):161-168.
40. Husain, K. et al. 2010. Effects of paricalcitol and enalapril on atherosclerotic injury in mouse aortas. Am J Nephrol 32(4):296-304.
41. Wei, M. Y. et al. 2008. Vitamin D and prevention of colorectal adenoma: a meta-analysis. Cancer Epidemiol Biomarkers Prev 17(11):2958-2969.
42. Kallay, E. et al 2002. Vitamin D receptor activity and prevention of colonic hyperproliferation and oxidative stress. Food Chem Toxicol 40(8):1191-1196.
43. Kallay, E. et al. 2001. Characterization of a vitamin D receptor knockout mouse as a model of colorectal hyperproliferation and DNA damage. Carcinogenesis 22(9):1429-1435.
44. Fedirko, V. et al. 2010. Effects of supplemental vitamin D and calcium on oxidative DNA damage marker in normal colorectal mucosa: A randomized clinical trial. Cancer Epidemiol Biomarkers Prev 19(1):280-291.
45. 3 receptor as a target for breast cancer prevention. J Nutr 133(7 Suppl):2425S-2433S.
46. 3) is an agonistic vitamin D receptor ligand. J Steroid Biochem Mol Biol 118(3):162-170.
47. 3 is a natural chemopreventive agent against carcinogen induced precancerous lesions in mouse mammary gland organ culture. Breast Cancer Res Treat 113(1):31-41.
48. 3 in breast epithelial cells. J Cell Biochem 110(6):1324-1333.
49. Krishnan, A. V. and D. Feldman. 2010. Molecular pathways mediating the anti-inflammatory effects of calcitriol: Implications for prostate cancer chemoprevention and treatment. Endocr Relat Cancer 17(1):R19-R38.
50. Toyokuni, S. 2006. Novel aspects of oxidative stress-associated carcinogenesis. Antioxid Redox Signal 8(7-8):1373-1377.
51. Kovalenko, P. L. et al. 2010. 1,25 dihydroxyvitamin D-mediated orchestration of anticancer, transcript-level effects in the immortalized, nontransformed prostate epithelial cell line, RWPE1. BMC Genomics 11:26.
52. 3 in primary cultures of human prostatic epithelial cells revealed by cDNA microarray analysis. J Steroid Biochem Mol Biol 92(3):131-141.
53. Krezel, A., Q. Hao, and W. Maret. 2007. The zinc/thiolate redox biochemistry of metallothionein and the control of zinc ion fluctuations in cell signaling. Arch Biochem Biophys 463(2):188-200.
54. 3 against oxidative stress in nonmalignant human prostate epithelial cells. Int J Cancer 122(12):2699-2706.
55. 3 prevents DNA damage and restores antioxidant enzymes in rat hepatocarcinogenesis induced by diethylnitrosamine and promoted by phenobarbital. World J Gastroenterol 10(9):1268-1275.
56. 3 on 3′methyl-4-dimethyl-amino-azobenzene-induced rat hepatocarcinogenesis: A study on antioxidant defense enzymes. J Exp Ther Oncol 2(4):193-199.
57. 3 inhibits hepatic chromosomal aberrations, DNA strand breaks and specific DNA adducts during rat hepatocarcinogenesis. Cell Mol Life Sci 58(8):1141-1149.
58. 3 suppresses the effect of streptozotocin-induced diabetes during chemical rat liver carcinogenesis. Cell Biol Int 25(3):227-237.
59. Preedy, V. R. et al. 2002. Free radicals in alcoholic myopathy: Indices of damage and preventive studies. Free Radic Biol Med 32(8):683-637.
60. Gonzalez-Reimers, E. et al. 2010. Alcoholic myopathy: Vitamin D deficiency is related to muscle fibre atrophy in a murine model. Alcohol Alcohol 45(3):223-230.
61. Tarcin, O. et al. 2009. Effect of vitamin D deficiency and replacement on endothelial function in asymptomatic subjects. J Clin Endocrinol Metab 94(10):4023-4030.
62. 3 in combination with a short induction course of cyclosporin A. Endocrinology 139(1):95-102.
63. 3 vitamin over oxidative stress and biochemical parameters in rats where type 1 diabetes is formed by streptozotocin. J Diabetes Complications 23(6):401-408.
64. Luca, G. et al. 2003. Multifunctional microcapsules for pancreatic islet cell entrapment: Design, preparation and in vitro characterization. Biomaterials 24(18):3101-3114.
65. Pop-Busui, R., A. Sima, and M. Stevens. 2006. Diabetic neuropathy and oxidative stress. Diabetes Metab Res Rev 22(4):257-273.
66. Greene, D. A. et al. 1999. Glucose-induced oxidative stress and programmed cell death in diabetic neuropathy. Eur J Pharmacol 375(1-3):217-223.
67. 3: Therapeutic and preventive effects against oxidative stress, hepatic, pancreatic and renal injury in alloxan-induced diabetes in rats. J Nutr Sci Vitaminol (Tokyo) 55(3):215-222.
68. 3 and Ajuga iva extract on oxidative stress, toxicity and hypo-fertility in diabetic rat testes. J Physiol Biochem 64(3):231-239.
69. Ravid, A. et al. 2002. Vitamin D inhibits the activation of stress-activated protein kinases by physiological and environmental stresses in keratinocytes. J Endocrinol 173(3):525-532.
70. Diker-Cohen, T. et al. 2003. Vitamin D protects keratinocytes from apoptosis induced by osmotic shock, oxidative stress, and tumor necrosis factor. Ann N Y Acad Sci 1010:350-353.
71. 3 on ultraviolet light B-induced damage in keratinocyte and its mechanism of action. J Dermatol Sci 18(1):11-18.
72. 3 is associated with an increase in p53 and a decrease in nitric oxide products. J Invest Dermatol 127(3):707-715.
73. 3 attenuated oxidative injuries in the locus coeruleus of rat brain. Ann N Y Acad Sci 993:313-324; Discussion 345-9.
74. 3 on zinc-induced oxidative stress in CNS. Ann N Y Acad Sci 1053:319-329.
75. 3 attenuates cyanide-induced neurotoxicity by inhibiting uncoupling protein-2 upregulation. J Neurosci Res 86(6):1397-1408.
76. 3 and dehydroascorbic acid administration attenuates brain damage in focal ischemia. Neurol Sci 30(3):207-212.
77. 3 in combination with 17beta-estradiol lowers the cortical expression of heat shock protein-27 following experimentally induced focal cortical ischemia in rats. Arch Biochem Biophys 439(1):70-79.
78. 3 and 17beta-estradiol reduces the expression of heat shock protein-32 (HSP-32) following cerebral cortical ischemia. J Steroid Biochem Mol Biol 89-90(1-5):371-374.
79. 3 treatment. J Steroid Biochem Mol Biol 97(1-2):57-64.
80. Marchionatti, A. M. et al. 2009. Antiproliferative action of menadione and 1,25(OH)2D3 on breast cancer cells. J Steroid Biochem Mol Biol 113(3-5):227-232.
81. 3 enhances the susceptibility of breast cancer cells to doxorubicin-induced oxidative damage. Cancer Res 59(4):862-867.
82. Weitsman, G. E. et al. 2005. Vitamin D sensitizes breast cancer cells to the action of H2O2: Mitochondria as a convergence point in the death pathway. Free Radic Biol Med 39(2):266-278.
83. Weitsman, G. E. et al. 2003. Vitamin D enhances caspase-dependent and -independent TNFalpha-induced breast cancer cell death: The role of reactive oxygen species and mitochondria. Int J Cancer 106(2):178-186.
84. 3) and immune cytokines: The involvement of reactive oxygen species. J Steroid Biochem Mol Biol 73(3-4):105-112.
85. Narvaez, C. J. and J. Welsh. 2001. Role of mitochondria and caspases in vitamin D-mediated apoptosis of MCF-7 breast cancer cells. J Biol Chem 276(12):9101-9107.
86. 3 and phorbol myristate acetate produce divergent phenotypes in a monomyelocytic cell line. Endocrinology 132(2):862-866.
87. 3. Biochim Biophys Acta 1219(1):26-32.
88. 3) upregulated protein 1 as a negative regulator of thioredoxin function and expression. J Biol Chem 274(31):21645-21650.
89. Yoshioka, J., E. R. Schreiter, and R. T. Lee. 2006. Role of thioredoxin in cell growth through interactions with signaling molecules. Antioxid Redox Signal 8(11-12):2143-2151.
90. 3 upregulated protein 1 mediates oxidative stress via suppressing the thioredoxin function. J Immunol 164(12):6287-6295.
91. 3 and seocalcitol in HL60 cells. Oncol Rep 18(6):1513-159.
92. 3) and its analog EB1089. Technol Cancer Res Treat 3(4):383-391.
93. 3, ergocalciferol, via reactive oxygen species generation, glutathione depletion, and caspase activation in human leukemia cells. J Agric Food Chem 56(9):2996-3005.
94. Monteiro, R. and I. Azevedo. 2010. Chronic inflammation in obesity and the metabolic syndrome. Mediators Inflamm.
95. Sun, X. and M. B. Zemel. 2006. Dietary calcium regulates ROS production in aP2-agouti transgenic mice on high-fat/high-sucrose diets. Int J Obes (Lond) 30(9):1341-1346.
96. 3 regulation of adipokine expression. Obesity (Silver Spring) 15(2):340-348.
97. Sun, X. and M. B. Zemel. 2008. Calcitriol and calcium regulate cytokine production and adipocyte-macrophage cross-talk. J Nutr Biochem 19(6):392-399.
98. 3 modulation of adipocyte reactive oxygen species production. Obesity (Silver Spring) 15(8):1944-1953.
99. Sun, X., K. L. Morris, and M. B. Zemel. 2008. Role of calcitriol and cortisol on human adipocyte proliferation and oxidative and inflammatory stress: A microarray study. J Nutrigenet Nutrigenomics 1(1-2):30-48.
100. Tang, F. T. et al. 2006. Hypercholesterolemia accelerates vascular calcification induced by excessive vitamin D via oxidative stress. Calcif Tissue Int 79(5):326-339.
101. 3) supplementation induces the development of aortic stenosis in rabbits: Interactions with endothelial function and thioredoxin-interacting protein. Eur J Pharmacol 590(1-3):290-296.
102. Serhan, C. N. et al. 2003. Reduced inflammation and tissue damage in transgenic rabbits overexpressing 15-lipoxygenase and endogenous anti-inflammatory lipid mediators. J Immunol 171(12):6856-6865.
103. Somjen, D. et al. 2010. Vitamin D analogs induce lipoxygenase mRNA expression and activity as well as reactive oxygen species (ROS) production in human bone cells. J Steroid Biochem Mol Biol 121(1-2):265-267.
104. Somjen, D. et al. 2011. Vitamin D metabolites and analogs induce lipoxygenase mRNA expression and activity as well as reactive oxygen species (ROS) production in human bone cell line. J Steroid Biochem Mol Biol 123(1-2):85-89.